ANANTNAG:SGMC Anantnag proudly announces the dual registration of its Ethics Committee by the Department of Health Research (DHR) and the Central Drugs Standard Control Organization (CDSCO) on April 18, 2024. This milestone underscores GMC Anantnag's commitment to advancing medical research and innovation, positioning it as a frontrunner in ethical biomedical studies, bioequivalence assessments, and clinical trials.
Led by the dedicated efforts of the committee members and with unwavering support from the institution's leadership, GMC Anantnag's Ethics Committee has achieved recognition from both apex bodies, affirming its adherence to national standards and regulatory requirements. Dr. Prof Anjum Farhana, Principal of GMC Anantnag, extends gratitude to all involved, emphasizing the significance of this achievement in advancing healthcare capabilities in the region.
Dr. Mansoor Ahmad, Member Secretary and Associate Professor at GMC Anantnag, lauds the collaborative spirit that facilitated this accomplishment, highlighting the committee's commitment to ethical practices and patient welfare.
Dr. Owais H Dar, Spokesperson GMC Anantnag, congratulates the department for its dedication and resilience, underscoring the importance of this milestone in aligning with national standards and fostering excellence in medical research.
The dual registration of GMC Anantnag's Ethics Committee marks a significant leap forward in the institution's pursuit of excellence in medical research and patient care. As they continue on this trajectory, GMC Anantnag remains steadfast in its mission to uphold ethical principles and drive advancements in healthcare on both regional and national fronts.